Cystic Fibrosis Canada / Fibrose kystique Canada
Registration:
9
of
31
(2013-08-02
to
2014-01-29)
Grant, Contribution or Other Financial Benefit, Policies or Program
- Increased federal investment in health-related research
Policies or Program
- Common Drug Review, importance of meaningful public/patient input into the drug review process
- Encouraging the development of an orphan product policy
Policies or Program, Regulation
- Health Canada with respect to the regulation of pancreatic enzymes used in the management of cystic fibrosis. Recommend product should be listed on Schedule F to the Food and Drugs Regulations.